Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.7888
-0.0112 (-1.40%)
At close: Aug 10, 2026, 4:00 PM EDT
0.8220
+0.0332 (4.21%)
After-hours: Aug 10, 2026, 7:37 PM EDT
Standard BioTools Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 84.91 | -74.9 | -138.89 | -74.66 | -190.1 | -59.24 |
Depreciation & Amortization | 5.49 | 10.98 | 16.86 | 15.18 | 15.03 | 15.57 |
Stock-Based Compensation | 27.09 | 29.61 | 31.73 | 13.12 | 14.88 | 16.1 |
Other Adjustments | -161.84 | -33.15 | -23.97 | 5.14 | 89.42 | 3.44 |
Change in Receivables | 0.33 | -1.36 | 8.97 | -2.99 | 1.06 | 6.73 |
Changes in Inventories | 0.21 | -11.52 | -9.88 | -4.91 | -8.47 | -4.78 |
Changes in Accounts Payable | 2.04 | 2.44 | -12.98 | 1.62 | -2.78 | 1.28 |
Changes in Accrued Expenses | -5.27 | 10.36 | 0.82 | 6.18 | 4.11 | -8.72 |
Changes in Unearned Revenue | -29.81 | -1.31 | -4.14 | 0.88 | -3.47 | -3.21 |
Changes in Other Operating Activities | -6.86 | -5.48 | -11.98 | -2.85 | -9.06 | -11.23 |
Operating Cash Flow | -80.3 | -74.34 | -143.45 | -43.29 | -89.37 | -44.06 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -2.28 | -8.3 | -8.36 | -2.83 | -3.83 | -13.26 |
Purchases of Investments | -202.57 | -143.29 | -256.12 | -94.9 | -137.3 | - |
Proceeds from Sale of Investments | 132 | 179 | 349 | 117.96 | 53 | - |
Cash Acquisitions | - | - | -1.39 | - | - | - |
Proceeds from Business Divestments | 388.21 | - | - | - | - | - |
Other Investing Activities | - | - | 280.03 | - | - | 1.32 |
Investing Cash Flow | 190.78 | 27.41 | 363.17 | 20.24 | -88.13 | -11.95 |
Short-Term Debt Issued | - | - | - | - | - | 6.84 |
Net Short-Term Debt Issued (Repaid) | - | - | - | - | - | 6.84 |
Long-Term Debt Issued | - | - | - | - | 25 | 10 |
Long-Term Debt Repaid | - | - | -63.19 | -2.08 | -6.84 | -0.08 |
Net Long-Term Debt Issued (Repaid) | - | - | -63.19 | -2.08 | 18.16 | 9.92 |
Issuance of Common Stock | 0.94 | 1.05 | 2.07 | 0.83 | 0.92 | 1.49 |
Repurchase of Common Stock | -0.61 | -0.48 | -40.95 | -5.55 | -0.77 | -2.29 |
Net Common Stock Issued (Repurchased) | 0.33 | 0.57 | -38.88 | -4.73 | 0.14 | -0.8 |
Issuance of Preferred Stock | - | - | - | - | 225 | - |
Net Preferred Stock Issued (Repurchased) | - | - | - | - | 225 | - |
Other Financing Activities | - | - | -0.55 | - | -12.55 | - |
Financing Cash Flow | 0.33 | 0.57 | -102.62 | -6.81 | 230.76 | 15.96 |
Foreign Exchange Rate Adjustments | 0.11 | 0.84 | -0.79 | 0.03 | -0.4 | -0.02 |
Net Cash Flow | 110.91 | -45.52 | 116.32 | -29.83 | 52.86 | -40.07 |
Free Cash Flow | -82.58 | -82.65 | -151.81 | -46.12 | -93.2 | -57.33 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -97.61% | -96.85% | -166.81% | -43.37% | -95.15% | -43.90% |
Free Cash Flow Per Share | -0.21 | -0.22 | -0.43 | -0.58 | -1.19 | -0.73 |
Levered Free Cash Flow | 48.44 | -152.64 | -138.86 | -138.13 | -370.49 | -66.83 |
Unlevered Free Cash Flow | -94.61 | -69.92 | -157.9 | -63.8 | -122.96 | -87.13 |